Selected research
Industry Research
Microbiota Transplantation Overall Solution Industry Research Report 2026
Market perspective
The global Microbiota Transplantation Overall Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microbiota Transplantation Overall Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microbiota Transplantation Overall Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microbiota Transplantation Overall Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microbiota Transplantation Overall Solution include Ferring Pharmaceuticals, Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health and Metabiomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Microbiota Transplantation Overall Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microbiota Transplantation Overall Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microbiota Transplantation Overall Solution Market by Company
Ferring Pharmaceuticals
Seres Therapeutics
Finch Therapeutics
OpenBiome
Vedanta Biosciences
MaaT Pharma
BiomX
Entera Health
Metabiomics
J-Pharma
KoBioLabs
Hangzhou Shengshi Technology
Ruiyi Biotechnology
Jiangsu Junkey Life Technology Development
Hangzhou Yuanxiang Medical Technology
MAUSOAR
Shanghai Chengge Biotechnology
Guangzhou Zhiyi Biotechnology
Shenzhen Unknown Jun Biotechnology
Sichuan Anaerobic Biotechnology
Microbiota Transplantation Overall Solution Segment by Type
Fresh Donor Flora Transplantation Protocol
Standard Frozen Flora Transplantation Protocol
Synthetic Flora Preparation Transplantation Protocol
Microbiota Transplantation Overall Solution Segment by Application
Medical and Health Industry
Scientific Research and Education Industry
Others
Microbiota Transplantation Overall Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiota Transplantation Overall Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiota Transplantation Overall Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiota Transplantation Overall Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microbiota Transplantation Overall Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Microbiota Transplantation Overall Solution Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Microbiota Transplantation Overall Solution Revenue Market Share by Type (2021-2026)
Table 7. Global Microbiota Transplantation Overall Solution Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Microbiota Transplantation Overall Solution Revenue Market Share by Type (2027-2032)
Table 9. Global Microbiota Transplantation Overall Solution Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Microbiota Transplantation Overall Solution Revenue Market Share by Application (2021-2026)
Table 11. Global Microbiota Transplantation Overall Solution Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Microbiota Transplantation Overall Solution Revenue Market Share by Application (2027-2032)
Table 13. Global Microbiota Transplantation Overall Solution Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Microbiota Transplantation Overall Solution Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Microbiota Transplantation Overall Solution Market Share by Region (2021-2026)
Table 16. Global Microbiota Transplantation Overall Solution Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Microbiota Transplantation Overall Solution Market Share by Region (2027-2032)
Table 18. Microbiota Transplantation Overall Solution Industry Trends
Table 19. Microbiota Transplantation Overall Solution Industry Drivers
Table 20. Microbiota Transplantation Overall Solution Industry Opportunities and Challenges
Table 21. Microbiota Transplantation Overall Solution Market Restraints
Table 22. Global Top Microbiota Transplantation Overall Solution Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Microbiota Transplantation Overall Solution Revenue Market Share by Players (2021-2026)
Table 24. Global Microbiota Transplantation Overall Solution Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Microbiota Transplantation Overall Solution, Headquarters and Area Served
Table 26. Global Microbiota Transplantation Overall Solution Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Microbiota Transplantation Overall Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Microbiota Transplantation Overall Solution Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Microbiota Transplantation Overall Solution Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Microbiota Transplantation Overall Solution Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Microbiota Transplantation Overall Solution Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Microbiota Transplantation Overall Solution Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Microbiota Transplantation Overall Solution Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Microbiota Transplantation Overall Solution Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Microbiota Transplantation Overall Solution Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Microbiota Transplantation Overall Solution Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Microbiota Transplantation Overall Solution Market Size by Country (2027-2032) & (US$ Million)
Table 45. Ferring Pharmaceuticals Company Information
Table 46. Ferring Pharmaceuticals Business Overview
Table 47. Ferring Pharmaceuticals Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 48. Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Product Portfolio
Table 49. Ferring Pharmaceuticals Recent Developments
Table 50. Seres Therapeutics Company Information
Table 51. Seres Therapeutics Business Overview
Table 52. Seres Therapeutics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 53. Seres Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
Table 54. Seres Therapeutics Recent Developments
Table 55. Finch Therapeutics Company Information
Table 56. Finch Therapeutics Business Overview
Table 57. Finch Therapeutics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 58. Finch Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
Table 59. Finch Therapeutics Recent Developments
Table 60. OpenBiome Company Information
Table 61. OpenBiome Business Overview
Table 62. OpenBiome Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 63. OpenBiome Microbiota Transplantation Overall Solution Product Portfolio
Table 64. OpenBiome Recent Developments
Table 65. Vedanta Biosciences Company Information
Table 66. Vedanta Biosciences Business Overview
Table 67. Vedanta Biosciences Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 68. Vedanta Biosciences Microbiota Transplantation Overall Solution Product Portfolio
Table 69. Vedanta Biosciences Recent Developments
Table 70. MaaT Pharma Company Information
Table 71. MaaT Pharma Business Overview
Table 72. MaaT Pharma Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 73. MaaT Pharma Microbiota Transplantation Overall Solution Product Portfolio
Table 74. MaaT Pharma Recent Developments
Table 75. BiomX Company Information
Table 76. BiomX Business Overview
Table 77. BiomX Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 78. BiomX Microbiota Transplantation Overall Solution Product Portfolio
Table 79. BiomX Recent Developments
Table 80. Entera Health Company Information
Table 81. Entera Health Business Overview
Table 82. Entera Health Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 83. Entera Health Microbiota Transplantation Overall Solution Product Portfolio
Table 84. Entera Health Recent Developments
Table 85. Metabiomics Company Information
Table 86. Metabiomics Business Overview
Table 87. Metabiomics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 88. Metabiomics Microbiota Transplantation Overall Solution Product Portfolio
Table 89. Metabiomics Recent Developments
Table 90. J-Pharma Company Information
Table 91. J-Pharma Business Overview
Table 92. J-Pharma Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 93. J-Pharma Microbiota Transplantation Overall Solution Product Portfolio
Table 94. J-Pharma Recent Developments
Table 95. KoBioLabs Company Information
Table 96. KoBioLabs Business Overview
Table 97. KoBioLabs Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 98. KoBioLabs Microbiota Transplantation Overall Solution Product Portfolio
Table 99. KoBioLabs Recent Developments
Table 100. Hangzhou Shengshi Technology Company Information
Table 101. Hangzhou Shengshi Technology Business Overview
Table 102. Hangzhou Shengshi Technology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 103. Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Product Portfolio
Table 104. Hangzhou Shengshi Technology Recent Developments
Table 105. Ruiyi Biotechnology Company Information
Table 106. Ruiyi Biotechnology Business Overview
Table 107. Ruiyi Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 108. Ruiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
Table 109. Ruiyi Biotechnology Recent Developments
Table 110. Jiangsu Junkey Life Technology Development Company Information
Table 111. Jiangsu Junkey Life Technology Development Business Overview
Table 112. Jiangsu Junkey Life Technology Development Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 113. Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Product Portfolio
Table 114. Jiangsu Junkey Life Technology Development Recent Developments
Table 115. Hangzhou Yuanxiang Medical Technology Company Information
Table 116. Hangzhou Yuanxiang Medical Technology Business Overview
Table 117. Hangzhou Yuanxiang Medical Technology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 118. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Product Portfolio
Table 119. Hangzhou Yuanxiang Medical Technology Recent Developments
Table 120. MAUSOAR Company Information
Table 121. MAUSOAR Business Overview
Table 122. MAUSOAR Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 123. MAUSOAR Microbiota Transplantation Overall Solution Product Portfolio
Table 124. MAUSOAR Recent Developments
Table 125. Shanghai Chengge Biotechnology Company Information
Table 126. Shanghai Chengge Biotechnology Business Overview
Table 127. Shanghai Chengge Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 128. Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
Table 129. Shanghai Chengge Biotechnology Recent Developments
Table 130. Guangzhou Zhiyi Biotechnology Company Information
Table 131. Guangzhou Zhiyi Biotechnology Business Overview
Table 132. Guangzhou Zhiyi Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 133. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
Table 134. Guangzhou Zhiyi Biotechnology Recent Developments
Table 135. Shenzhen Unknown Jun Biotechnology Company Information
Table 136. Shenzhen Unknown Jun Biotechnology Business Overview
Table 137. Shenzhen Unknown Jun Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 138. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
Table 139. Shenzhen Unknown Jun Biotechnology Recent Developments
Table 140. Sichuan Anaerobic Biotechnology Company Information
Table 141. Sichuan Anaerobic Biotechnology Business Overview
Table 142. Sichuan Anaerobic Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026) & (US$ Million)
Table 143. Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
Table 144. Sichuan Anaerobic Biotechnology Recent Developments
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Microbiota Transplantation Overall Solution Product Image
Figure 5. Global Microbiota Transplantation Overall Solution Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Microbiota Transplantation Overall Solution Market Share by Type: 2025 VS 2032
Figure 7. Fresh Donor Flora Transplantation Protocol Product
Figure 8. Standard Frozen Flora Transplantation Protocol Product
Figure 9. Synthetic Flora Preparation Transplantation Protocol Product
Figure 10. Global Microbiota Transplantation Overall Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Microbiota Transplantation Overall Solution Market Share by Application: 2025 VS 2032
Figure 12. Medical and Health Industry Product
Figure 13. Scientific Research and Education Industry Product
Figure 14. Others Product
Figure 15. Global Microbiota Transplantation Overall Solution Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global Microbiota Transplantation Overall Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global Microbiota Transplantation Overall Solution Market Share by Region: 2025 VS 2032
Figure 18. Global Microbiota Transplantation Overall Solution Market Share by Players in 2025
Figure 19. Global Microbiota Transplantation Overall Solution Manufacturers Established Date
Figure 20. Global Top 5 and 10 Microbiota Transplantation Overall Solution Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 24. United States Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 27. Europe Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 29. Germany Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 39. China Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 44. Australia Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Microbiota Transplantation Overall Solution Market Share by Country (2021-2032)
Figure 49. Brazil Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru Microbiota Transplantation Overall Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Ferring Pharmaceuticals Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 55. Seres Therapeutics Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 56. Finch Therapeutics Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 57. OpenBiome Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 58. Vedanta Biosciences Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 59. MaaT Pharma Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 60. BiomX Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 61. Entera Health Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 62. Metabiomics Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 63. J-Pharma Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 64. KoBioLabs Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 65. Hangzhou Shengshi Technology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 66. Ruiyi Biotechnology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 67. Jiangsu Junkey Life Technology Development Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 68. Hangzhou Yuanxiang Medical Technology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 69. MAUSOAR Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 70. Shanghai Chengge Biotechnology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 71. Guangzhou Zhiyi Biotechnology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 72. Shenzhen Unknown Jun Biotechnology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Figure 73. Sichuan Anaerobic Biotechnology Revenue Growth Rate in Microbiota Transplantation Overall Solution Business (2021-2026)
Scope & coverage.
Types
- Fresh Donor Flora Transplantation Protocol
- Standard Frozen Flora Transplantation Protocol
- Synthetic Flora Preparation Transplantation Protocol
Applications
- Medical and Health Industry
- Scientific Research and Education Industry
- Others
Companies covered
- Ferring Pharmaceuticals
- Seres Therapeutics
- Finch Therapeutics
- OpenBiome
- Vedanta Biosciences
- MaaT Pharma
- BiomX
- Entera Health
- Metabiomics
- J-Pharma
- KoBioLabs
- Hangzhou Shengshi Technology
- Ruiyi Biotechnology
- Jiangsu Junkey Life Technology Development
- Hangzhou Yuanxiang Medical Technology
- MAUSOAR
- Shanghai Chengge Biotechnology
- Guangzhou Zhiyi Biotechnology
- Shenzhen Unknown Jun Biotechnology
- Sichuan Anaerobic Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microbiota Transplantation Overall Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Fresh Donor Flora Transplantation Protocol
- 2.2.3 Standard Frozen Flora Transplantation Protocol
- 2.2.4 Synthetic Flora Preparation Transplantation Protocol
- 2.3 Microbiota Transplantation Overall Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical and Health Industry
- 2.3.3 Scientific Research and Education Industry
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Microbiota Transplantation Overall Solution Breakdown Data by Type
- 3.1 Global Microbiota Transplantation Overall Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Microbiota Transplantation Overall Solution Forecasted Market Size by Type (2027-2032)
4 Microbiota Transplantation Overall Solution Breakdown Data by Application
- 4.1 Global Microbiota Transplantation Overall Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Microbiota Transplantation Overall Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microbiota Transplantation Overall Solution Market Perspective (2021-2032)
- 5.2 Global Microbiota Transplantation Overall Solution Growth Trends by Region
- 5.2.1 Global Microbiota Transplantation Overall Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microbiota Transplantation Overall Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Microbiota Transplantation Overall Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Microbiota Transplantation Overall Solution Market Dynamics
- 5.3.1 Microbiota Transplantation Overall Solution Industry Trends
- 5.3.2 Microbiota Transplantation Overall Solution Market Drivers
- 5.3.3 Microbiota Transplantation Overall Solution Market Challenges
- 5.3.4 Microbiota Transplantation Overall Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microbiota Transplantation Overall Solution Players by Revenue
- 6.1.1 Global Top Microbiota Transplantation Overall Solution Players by Revenue (2021-2026)
- 6.1.2 Global Microbiota Transplantation Overall Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Microbiota Transplantation Overall Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microbiota Transplantation Overall Solution Head Office and Area Served
- 6.4 Global Microbiota Transplantation Overall Solution Players, Product Type & Application
- 6.5 Global Microbiota Transplantation Overall Solution Manufacturers Established Date
- 6.6 Global Microbiota Transplantation Overall Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microbiota Transplantation Overall Solution Market Size (2021-2032)
- 7.2 North America Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microbiota Transplantation Overall Solution Market Size by Country (2021-2026)
- 7.4 North America Microbiota Transplantation Overall Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microbiota Transplantation Overall Solution Market Size (2021-2032)
- 8.2 Europe Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microbiota Transplantation Overall Solution Market Size by Country (2021-2026)
- 8.4 Europe Microbiota Transplantation Overall Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microbiota Transplantation Overall Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microbiota Transplantation Overall Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microbiota Transplantation Overall Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microbiota Transplantation Overall Solution Market Size (2021-2032)
- 10.2 South America Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microbiota Transplantation Overall Solution Market Size by Country (2021-2026)
- 10.4 South America Microbiota Transplantation Overall Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microbiota Transplantation Overall Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Microbiota Transplantation Overall Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microbiota Transplantation Overall Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microbiota Transplantation Overall Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Ferring Pharmaceuticals
- 12.1.1 Ferring Pharmaceuticals Company Information
- 12.1.2 Ferring Pharmaceuticals Business Overview
- 12.1.3 Ferring Pharmaceuticals Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.1.4 Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Product Portfolio
- 12.1.5 Ferring Pharmaceuticals Recent Developments
- 12.2 Seres Therapeutics
- 12.2.1 Seres Therapeutics Company Information
- 12.2.2 Seres Therapeutics Business Overview
- 12.2.3 Seres Therapeutics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.2.4 Seres Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
- 12.2.5 Seres Therapeutics Recent Developments
- 12.3 Finch Therapeutics
- 12.3.1 Finch Therapeutics Company Information
- 12.3.2 Finch Therapeutics Business Overview
- 12.3.3 Finch Therapeutics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.3.4 Finch Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
- 12.3.5 Finch Therapeutics Recent Developments
- 12.4 OpenBiome
- 12.4.1 OpenBiome Company Information
- 12.4.2 OpenBiome Business Overview
- 12.4.3 OpenBiome Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.4.4 OpenBiome Microbiota Transplantation Overall Solution Product Portfolio
- 12.4.5 OpenBiome Recent Developments
- 12.5 Vedanta Biosciences
- 12.5.1 Vedanta Biosciences Company Information
- 12.5.2 Vedanta Biosciences Business Overview
- 12.5.3 Vedanta Biosciences Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.5.4 Vedanta Biosciences Microbiota Transplantation Overall Solution Product Portfolio
- 12.5.5 Vedanta Biosciences Recent Developments
- 12.6 MaaT Pharma
- 12.6.1 MaaT Pharma Company Information
- 12.6.2 MaaT Pharma Business Overview
- 12.6.3 MaaT Pharma Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.6.4 MaaT Pharma Microbiota Transplantation Overall Solution Product Portfolio
- 12.6.5 MaaT Pharma Recent Developments
- 12.7 BiomX
- 12.7.1 BiomX Company Information
- 12.7.2 BiomX Business Overview
- 12.7.3 BiomX Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.7.4 BiomX Microbiota Transplantation Overall Solution Product Portfolio
- 12.7.5 BiomX Recent Developments
- 12.8 Entera Health
- 12.8.1 Entera Health Company Information
- 12.8.2 Entera Health Business Overview
- 12.8.3 Entera Health Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.8.4 Entera Health Microbiota Transplantation Overall Solution Product Portfolio
- 12.8.5 Entera Health Recent Developments
- 12.9 Metabiomics
- 12.9.1 Metabiomics Company Information
- 12.9.2 Metabiomics Business Overview
- 12.9.3 Metabiomics Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.9.4 Metabiomics Microbiota Transplantation Overall Solution Product Portfolio
- 12.9.5 Metabiomics Recent Developments
- 12.10 J-Pharma
- 12.10.1 J-Pharma Company Information
- 12.10.2 J-Pharma Business Overview
- 12.10.3 J-Pharma Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.10.4 J-Pharma Microbiota Transplantation Overall Solution Product Portfolio
- 12.10.5 J-Pharma Recent Developments
- 12.11 KoBioLabs
- 12.11.1 KoBioLabs Company Information
- 12.11.2 KoBioLabs Business Overview
- 12.11.3 KoBioLabs Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.11.4 KoBioLabs Microbiota Transplantation Overall Solution Product Portfolio
- 12.11.5 KoBioLabs Recent Developments
- 12.12 Hangzhou Shengshi Technology
- 12.12.1 Hangzhou Shengshi Technology Company Information
- 12.12.2 Hangzhou Shengshi Technology Business Overview
- 12.12.3 Hangzhou Shengshi Technology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.12.4 Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Product Portfolio
- 12.12.5 Hangzhou Shengshi Technology Recent Developments
- 12.13 Ruiyi Biotechnology
- 12.13.1 Ruiyi Biotechnology Company Information
- 12.13.2 Ruiyi Biotechnology Business Overview
- 12.13.3 Ruiyi Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.13.4 Ruiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
- 12.13.5 Ruiyi Biotechnology Recent Developments
- 12.14 Jiangsu Junkey Life Technology Development
- 12.14.1 Jiangsu Junkey Life Technology Development Company Information
- 12.14.2 Jiangsu Junkey Life Technology Development Business Overview
- 12.14.3 Jiangsu Junkey Life Technology Development Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.14.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Product Portfolio
- 12.14.5 Jiangsu Junkey Life Technology Development Recent Developments
- 12.15 Hangzhou Yuanxiang Medical Technology
- 12.15.1 Hangzhou Yuanxiang Medical Technology Company Information
- 12.15.2 Hangzhou Yuanxiang Medical Technology Business Overview
- 12.15.3 Hangzhou Yuanxiang Medical Technology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.15.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Product Portfolio
- 12.15.5 Hangzhou Yuanxiang Medical Technology Recent Developments
- 12.16 MAUSOAR
- 12.16.1 MAUSOAR Company Information
- 12.16.2 MAUSOAR Business Overview
- 12.16.3 MAUSOAR Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.16.4 MAUSOAR Microbiota Transplantation Overall Solution Product Portfolio
- 12.16.5 MAUSOAR Recent Developments
- 12.17 Shanghai Chengge Biotechnology
- 12.17.1 Shanghai Chengge Biotechnology Company Information
- 12.17.2 Shanghai Chengge Biotechnology Business Overview
- 12.17.3 Shanghai Chengge Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.17.4 Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
- 12.17.5 Shanghai Chengge Biotechnology Recent Developments
- 12.18 Guangzhou Zhiyi Biotechnology
- 12.18.1 Guangzhou Zhiyi Biotechnology Company Information
- 12.18.2 Guangzhou Zhiyi Biotechnology Business Overview
- 12.18.3 Guangzhou Zhiyi Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.18.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
- 12.18.5 Guangzhou Zhiyi Biotechnology Recent Developments
- 12.19 Shenzhen Unknown Jun Biotechnology
- 12.19.1 Shenzhen Unknown Jun Biotechnology Company Information
- 12.19.2 Shenzhen Unknown Jun Biotechnology Business Overview
- 12.19.3 Shenzhen Unknown Jun Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.19.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
- 12.19.5 Shenzhen Unknown Jun Biotechnology Recent Developments
- 12.20 Sichuan Anaerobic Biotechnology
- 12.20.1 Sichuan Anaerobic Biotechnology Company Information
- 12.20.2 Sichuan Anaerobic Biotechnology Business Overview
- 12.20.3 Sichuan Anaerobic Biotechnology Revenue in Microbiota Transplantation Overall Solution Business (2021-2026)
- 12.20.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
- 12.20.5 Sichuan Anaerobic Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst